Abiozen is a regulatory-driven, AI-enabled life-science platform supporting early-stage and virtual biotech companies from research molecule sourcing through quality control and early clinical development.

By integrating research molecules, generic APIs, analytical QC testing, and early-stage clinical execution into a single operating framework, Abiozen reduces vendor fragmentation, accelerates timelines, and improves data integrity for first-in-human and early development programs.